筛选条件 共查询到111条结果
排序方式
Shark mouth pancreaticojejunostomy reduced the rate of clinically related pancreatic fistula: a historic cohort comparative analysis

期刊: HPB, 2022; 24 (5)

Background: A novel procedure called shark mouth pancreaticojejunostomy (SMP) was developed, for the reconstruction of the pancreatic stump which has ......

JIF:2.822

Comparison of early postoperative outcomes between omega-like duct-to-mucosa pancreatojejunostomy and conventional duct-to-mucosa pancreatojejunostomy after pancreaticoduodenectomy

期刊: HPB, 2022; 24 (5)

Background: Pancreatic fistula is a life-threatening complication of pancreaticoduodenectomy. Omega-like duct-to-mucosa pancreatojejunostomy is a nove......

JIF:2.822

Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor

期刊: HPB, 2022; 24 (12)

Background: Routine lymphadenectomy in pancreatic neuroendocrine tumors (pNETs) is debated. There lacks accurate model to predict lymph node metastasi......

JIF:2.822

Tumor location influences perioperative and oncologic outcomes in solitary intrahepatic cholangiocarcinoma following curative resection: a multi-center analysis

期刊: HPB, 2022; 24 (9)

Background: To compare perioperative and oncologic outcomes of patients with different locations of Methods: A total of 352 ICC patients underwent cur......

JIF:2.822

Should associating liver partition and portal vein ligation for staged hepatectomy be applied to hepatitis B virus-related hepatocellular carcinoma patients with cirrhosis? A multi-center study

期刊: HPB, 2022; 24 (12)

Background: It is unclear whether associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can be performed in hepatitis B ......

JIF:2.822

Major adverse kidney events within 30 days in patients with acute pancreatitis: a tertiary-center cohort study

期刊: HPB, 2022; 24 (2)

Background: To evaluate the event rate of major adverse kidney events within 30 days (MAKE30) in acute pancreatitis (AP) and its potential risk factor......

JIF:2.822

Long disease-free interval diminishes the prognostic value of primary tumor stage for patients with colorectal cancer liver metastases

期刊: HPB, 2022; 24 (5)

Background: It is assumed that the impact of primary tumor stage (PTS) on prognosis gradually weakens with increasing disease-free interval (DFI) from......

JIF:2.822

Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China

期刊: HPB, 2022; 24 (7)

Background: Microvascular invasion (MVI) is a risk factor of post-hepatectomy tumor recurrence for hepatocellular carcinoma (HCC). The patterns, treat......

JIF:2.822

Predicting persistent organ failure on admission in patients with acute pancreatitis: development and validation of a mobile nomogram

期刊: HPB, 2022; 24 (11)

Background: Early prediction of persistent organ failure (POF) is important for triage and timely treat-ment of patients with acute pancreatitis (AP).......

JIF:2.822

Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study

期刊: HPB, 2022; 24 (10)

Background: Patients with hepatocellular carcinoma (HCC) bile duct tumor thrombus (BDTT) have a high rate of postoperative recurrence. We aimed to des......

JIF:2.822

Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors

期刊: HPB, 2022; 24 (5)

Background: The American Joint Committee on Cancer (AJCC) made improvements for staging pancreatic neuroendocrine tumors (pNETs) in its 8th Edition; h......

JIF:2.822

Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey

期刊: HPB, 2022; 24 (3)

Background: This study aimed to investigate the work status of clinicians in China and their management strategy alteration for patients with hepatoce......

JIF:2.822

Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with bile duct tumor thrombus: a propensity score matching analysis

期刊: HPB, 2022; 24 (4)

Background: Surgical resection is the primary treatment for hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT). This study was conduc......

JIF:2.822

共111条页码: 1/8页15条/页